Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16014024rdf:typepubmed:Citationlld:pubmed
pubmed-article:16014024lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16014024lifeskim:mentionsumls-concept:C0227651lld:lifeskim
pubmed-article:16014024lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:16014024lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:16014024lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:16014024lifeskim:mentionsumls-concept:C0297001lld:lifeskim
pubmed-article:16014024pubmed:issue2lld:pubmed
pubmed-article:16014024pubmed:dateCreated2005-7-14lld:pubmed
pubmed-article:16014024pubmed:abstractTextMany of the proliferative cytokines implicated in human mesangial cell (HMC) proliferation signal through the superfamily of Ras GTPases. The Ras antagonist, S-trans, trans- farnesylthiosalicylic acid (FTS), was used to investigate the effects of the inhibition of Ras signaling on HMC proliferation.lld:pubmed
pubmed-article:16014024pubmed:languageenglld:pubmed
pubmed-article:16014024pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:citationSubsetIMlld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16014024pubmed:statusMEDLINElld:pubmed
pubmed-article:16014024pubmed:monthAuglld:pubmed
pubmed-article:16014024pubmed:issn0085-2538lld:pubmed
pubmed-article:16014024pubmed:authorpubmed-author:KloogYoelYlld:pubmed
pubmed-article:16014024pubmed:authorpubmed-author:SharpeClaire...lld:pubmed
pubmed-article:16014024pubmed:authorpubmed-author:HendryBruce...lld:pubmed
pubmed-article:16014024pubmed:authorpubmed-author:KhwajaArifAlld:pubmed
pubmed-article:16014024pubmed:authorpubmed-author:NoorMazharMlld:pubmed
pubmed-article:16014024pubmed:issnTypePrintlld:pubmed
pubmed-article:16014024pubmed:volume68lld:pubmed
pubmed-article:16014024pubmed:ownerNLMlld:pubmed
pubmed-article:16014024pubmed:authorsCompleteYlld:pubmed
pubmed-article:16014024pubmed:pagination474-86lld:pubmed
pubmed-article:16014024pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:meshHeadingpubmed-meshheading:16014024...lld:pubmed
pubmed-article:16014024pubmed:year2005lld:pubmed
pubmed-article:16014024pubmed:articleTitleThe inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.lld:pubmed
pubmed-article:16014024pubmed:affiliationDepartment of Renal Medicine, GKT School of Medicine, King's College London, London, United Kingdom.lld:pubmed
pubmed-article:16014024pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16014024pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed